AR	androgen receptor
CR	complete remission
DFI	disease free interval
EMT	epithelial mesenchymal transition
ER	estrogen receptor
ER+	estrogen receptor positive
ESR1	estrogen receptor 1
FOXO	forkhead box O
fRMA	frozen robust multiarray analysis
HER2	human epidermal growth factor receptor 2
HH	hedgehog
LRR	local regional relapse
M0	metastasis negative
NFκB	nuclear factor kappa B
OR	odds ratio
PD	progressive disease
PFS	progression-free survival
PGR	progesterone receptor
PI3K	phosphoinositide 3-kinase
PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha
PR	partial remission
PR	progesterone receptor
PS	probeset
pT	pathological tumor classification
QC	quality control
RT-qPCR	reverse-transcription quantitative polymerase chain reaction
SD	stable disease
SOD2	superoxide dismutase 2
TC	transcription complex
TF	transcription factor
TG	target gene
TGFb	transforming growth factor beta
UICC	Unio Internationale Contra Cancrum